Search results
Showing results for
Early Psychosis Research Group
We undertake research across the translational spectrum, ranging from basis science studies, through to trials of new treatments and approaches for psychosis, right through to researching clinical services and their effectiveness. We work closely with the Oxfordshire Early Intervention in Psychosis Service in Oxford Health NHS FT. This service provides high quality, multi-discliplinary care for people experiencing first episode of psychosis and their families. We also lead the Early Intervention Psychosis network for the NHS in the South of England, providing the opportunity to speed up the translation of new research findings into routine clinical care. You can find out more about our current studies below.
Oxford Precision Psychiatry Lab
We are an international multidisciplinary group of researchers, clinicians (both psychiatrists and psychologists), statisticians, methodologists and students who aim to improve the current treatment practice in the NHS and across the world, using innovative approaches from artificial intelligence and machine learning, to digital mental health and bioethics.
Computational and Molecular Neuroscience
The Computational and Molecular Neuroscience Research Group is a multidisciplinary laboratory specialized on the intersection of computational and molecular methods to study neurodegenerative diseases. The computational methods entail mainly Artificial Intelligence and Bioinformatics, while the molecular side brings state of the art multi-culture iPSC models of disease and high throughput screening. We are especially interested in Alzheimer's and Parkinson’s disease, and how we can use the computational and molecular methods mentioned above to find new drug targets and therapies. We have three main areas of activity: better understanding disease to identify new therapies; discovering biomarkers to enable preventative trials; and validating findings in advanced cell models of disease.
Translational Neuroimaging
- Alzheimer's
- Brain
- Brain function
- Brain imaging
- Clinical trial
- Cognitive models
- Cohorts
- Dementia
- Empirical
- Functional imaging
- Genetics
- Magnetic Resonance Imaging (MRI)
- Medical imaging
- Neuroimaging
- Neurology
- Neuroscience
- Parkinson's
- Risk factors
- Whitehall Study
Neuroimaging provides a window into the living brain, and is an increasingly vital experimental medicine tool for neuro-psychiatric disease. With a particular focus on early and pre-clinical disease, we explore how the brain changes before symptoms take hold.
Centre for Research on Eating Disorders at Oxford
- Clinical trial
- Dissemination
- Distribution
- Epidemiology
- Evidence based treatment
- Prevention
- Psychological treatment development and evaluation
CREDO was established in 1981. The main focus of its research is on the treatment of eating disorders. More recently, it has also developed methods to facilitate the dissemination of effective psychological interventions. It is in the process of creating a digital treatment for eating disorders (Digital CBTe).
University of Oxford Mindfulness and Psychological Science Research Centre
- Behaviour
- Child development
- Clinical psychology
- Clinical trial
- Cognitive models
- Depression
- Evidence based treatment
- Mindfulness
- Mood
- Self-harm
Our work focuses on preventing depression, promoting mental health and human flourishing - and resourcing people to meet the challenges of the 21st century.